Bone marrow concentrate implantation alongside decompression of no benefit in ONFH treatment
Inefficacy of autologous bone marrow concentrate in stage three osteonecrosis: a randomized controlled double-blind trialInt Orthop. 2018 Jul;42(7):1429-1435. doi: 10.1007/s00264-017-3650-8. Epub 2017 Oct 7
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
42 patients with osteonecrosis of the femoral head (ONFH) were randomized to core decompression with or without additional application of bone marrow aspirate concentrate (BMAC). The purpose of this study was to compare the rate of conversion to total hip arthroplasty (THA) during follow-up to 24 months. Results demonstrated no significant difference between the groups in the rate of eventual THA.
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE